HSK31679

DRUG2 trials

Sponsors

Haisco Pharmaceutical Group Co., Ltd.

Conditions

Elevated LDL-CHealthyMASH - Metabolic Dysfunction-Associated SteatohepatitisNASH (Non-Alcoholic Steatohepatitis)

Phase 1

Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C

CompletedNCT05531097

Haisco Pharmaceutical Group Co., Ltd.Elevated LDL-C, Healthy

Start: 2022-02-22End: 2022-12-08Updated: 2024-01-03

Phase 3

A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

Not yet recruitingNCT07581951

Haisco Pharmaceutical Group Co., Ltd.MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH (Non-Alcoholic Steatohepatitis)

Start: 2026-06-30End: 2032-12-30Target: 400Updated: 2026-06-17